You are here

COVID-19

Moderna's Latest Move May be Key to COVID-19 Vaccine Market Dominance

Moderna's Latest Move May be Key to COVID-19 Vaccine Market Dominance

Motley Fool

Moderna Therapeutics

Flag link:

Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay

Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay

FDA Law Blog

Roche Molecular Systems

Flag link:

AstraZeneca Troubles Continue as Study Shows Ineffectiveness Against South African Variant

AstraZeneca Troubles Continue as Study Shows Ineffectiveness Against South African Variant

BioSpace

COVID-19 variants

Flag link:

Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says

Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says

Endpoints

COVID-19 variants

Flag link:

FDA authorizes first COVID test via traditional review pathway

FDA authorizes first COVID test via traditional review pathway

RAPS.org

BioFire Diagnostics

Flag link:

Pfizer expects higher COVID-19 vaccine prices and yearly boosters, CFO says. And that means big sales long-term

Pfizer expects higher COVID-19 vaccine prices and yearly boosters, CFO says. And that means big sales long-term

Fierce Pharma

Flag link:

New French coronavirus variant appears to bypass standard tests

New French coronavirus variant appears to bypass standard tests

Politico

COVID-19 variants

Flag link:

AstraZeneca vaccine risk is ‘not concerning, appears more politically motivated’: doctor

AstraZeneca vaccine risk is ‘not concerning, appears more politically motivated’: doctor

Yahoo Finance

Flag link:

CDC: Most people return for second COVID-19 vaccine dose

CDC: Most people return for second COVID-19 vaccine dose

Beckers Hospital Review

Flag link:

Europe mulls halting Covid-19 vaccine exports to some countries

Europe mulls halting Covid-19 vaccine exports to some countries

Endpoints

Flag link:

Merck KGaA foresees post-pandemic localization of biologics supply chains

Merck KGaA foresees post-pandemic localization of biologics supply chains

Biopharma Reporter

Flag link:

AstraZeneca Vaccine: Here’s What To Expect As Europe’s Medicines Regulator And The WHO Meet To Review Shot

AstraZeneca Vaccine: Here’s What To Expect As Europe’s Medicines Regulator And The WHO Meet To Review Shot

Forbes

Flag link:

Roche launches test to monitor emerging coronavirus variants

Roche launches test to monitor emerging coronavirus variants

Pharmaforum

COVID-19 variants

Flag link:

Pharma looks to spotlight need for more patients—and diversity—in COVID-19 trials

Pharma looks to spotlight need for more patients—and diversity—in COVID-19 trials

Fierce Pharma

clinical trials

clinical trial diversity

Flag link:

Medicare payment for Covid-19 vaccines jumps to $40-$80

Medicare payment for Covid-19 vaccines jumps to $40-$80

MedCity News

Flag link:

GSK kick-starts phase 3 Medicago-partnered COVID vaccine test

GSK kick-starts phase 3 Medicago-partnered COVID vaccine test

Fierce Biotech

Flag link:

Moderna Starts Covid-19 Vaccine Trial In Kids Younger Than 12 Years Old

Moderna Starts Covid-19 Vaccine Trial In Kids Younger Than 12 Years Old

Forbes

Moderna Therapeutics

clinical trials

Flag link:

BIO chair slams Trump’s HHS, calls to stop Russian disinformation campaign on vaccines

BIO chair slams Trump’s HHS, calls to stop Russian disinformation campaign on vaccines

Endpoints

Flag link:

FDA launches FAERS dashboard for COVID-19 therapies

FDA launches FAERS dashboard for COVID-19 therapies

RAPS.org

Flag link:

The curious case of AstraZeneca’s Covid-19 vaccine

The curious case of AstraZeneca’s Covid-19 vaccine

Stat

Flag link:

Pages